New PET imaging biomarker Gal-1 predicts tumor responses to immunotherapy

FHS
May 15, 2024
4:42 pm

The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.

Rallybio and J&J collaborate to tackle maternal-foetal blood disorder – Pharmaceutical Technology

Share this article With no approved therapies, there is a high unmet need for preventative and prenatal treatments for FNAIT. Credits: fizkes/Shutterstock.com Rallybio has announced

April 13, 2024

HCA discloses massive data breach affecting 11 million patients

HCA Healthcare revealed Monday that it’s experienced what is likely the largest data breach ever reported by a health care provider, with approximately 11 million

July 10, 2023

Prolonged Grief Disorder rates during COVID-19 pandemic found to be higher than pre-pandemic times

Cases of Prolonged Grief Disorder among people bereaved during the COVID-19 pandemic are likely to be significantly higher than pre-pandemic, indicates new research from the

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.